Planet Labs Posts Record Quarterly Revenue, Stock Slides Anyway - Planet Labs (NYSE:PL)
Planet Labs reported Q1 adjusted loss of 3 cents per share, better than the 4-cent consensus, and revenue of $94.15 million, above the $89.85 million estimate and up 42% year over year. Remaining performance obligations rose to $816 million and backlog to $906+ million. The company raised FY2027 revenue guidance to $425–$441 million. Shares were down about 7.6% to $40.22.
Fundamentals improved (revenue, backlog, cash, guidance), but the market reaction is negative, suggesting valuation/expectations or technical positioning is dominating short-term.
Planet Labs beat Q1 revenue and raised FY2027 guidance, yet the stock slid ~7.6% as traders focused on near-term reset levels.
Choppy-to-soft near term with resistance around the 20-day SMA/pivot (~$41.50) and support near ~$38; direction likely depends on follow-through buying after the guidance beat.
Background
Planet Labs reported Q1 results with strong revenue growth, rising remaining performance obligations/backlog, and redeemed public warrants; it also launched three Pelican satellites.
Why it matters
Despite beating on revenue and raising FY2027 guidance, the stock fell sharply, indicating the market may be reacting to expectations, margin/trajectory concerns not detailed here, or technical resistance near the 20-day SMA.
Market relevance
A guidance raise and strong backlog/cash are positive, but the immediate market reaction is negative, making the near-term technical levels ($41.50 resistance, ~$38 support) especially relevant for traders.
Market effects
Reinforces that satellite-data operators can show strong backlog visibility, but equity markets may still punish near-term expectations/valuation.
Limited; primarily single-name reaction with no explicit regional spillover.
Some global relevance via sovereign reconnaissance satellite launch, but the trading catalyst is company-specific guidance and results.
Alternative perspectives
The guidance raise plus large backlog/cash increase may be underappreciated; the selloff could be a buying opportunity if price reclaims the $41.50 pivot area.
The article’s technical framing (below 20-day SMA) may be amplifying selling despite fundamentals; traders should watch whether momentum stabilizes (RSI ~neutral) and whether support near ~$38 holds.
Key entities
- companyPlanet Labs
Subject of the article; Q1 beat, raised FY2027 revenue guidance, and experienced a same-day share decline.
- personWill Marshall
CEO quoted on mission-critical data and the company’s outlook.
- analyst_firmNeedham
Raised its price target to $53 and reiterated Buy on June 5.
